Hypothetic immunopathological impacts of SARS-CoV-2 and HIV co-infection on COVID-19 severity

Submitted: 15 April 2020
Accepted: 6 May 2020
Published: 15 May 2020
Abstract Views: 930
PDF: 486
HTML: 9
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

To the Editor, The world is currently battling against and trying to survive yet another pandemic that threatens human health security. Severe acute respiratory syndromecoronavirus- 2 (SARS-CoV-2), the etiological agent of coronavirus disease 19 (COVID-19), is one of the three most virulent coronaviruses (CoVs). Based on available clinical details, the geriatric group of over 65 years of age and persons with chronic comorbidities such as type-2 diabetes mellitus, chronic obstructive pulmonary disease, cardiovascular diseases, and immunodeficiencies tend to rapidly develop multiorgan failure, severe COVID-19 and ultimately, death...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Abdullahi, I. N., Ahmad, A. E., & Emeribe, A. U. (2020). Hypothetic immunopathological impacts of SARS-CoV-2 and HIV co-infection on COVID-19 severity. Italian Journal of Medicine, 14(3), 189–191. https://doi.org/10.4081/itjm.2020.1291